Lufax (LU) Q3 2026 Earnings Call Transcript

Lufax reported a Q3 2026 net loss of RMB 1.494 billion, versus RMB 380 million a year earlier, driven mainly by higher credit impairment losses and a RMB 773 million tax expense that included non-cash charges. Total income fell 4.6% year over year to RMB 6.180 billion, while credit impairment losses rose 10.3% to RMB 4.511 billion; management cited weak demand, tighter liquidity and increased regulatory scrutiny of debt collection. New loan sales increased 2.5% to RMB 58.3 billion, and consumer finance loan sales grew 25.2% to RMB 39.7 billion, but the total-loan C-M3 flow rate worsened to 1.2% from 1.0% in Q2. Management said risk volatility may persist for a couple of months, while funding costs excluding consumer finance declined 20 basis points sequentially to 3.6%.

Analysis

The key issue is not simply this quarter’s loss: Lufax is absorbing more of the credit and collection cycle while legacy assets underperform. With 95.8% of balances company-risk-bearing, weaker recoveries can flow through provisions and earnings even if new originations hold up. Management’s claim that 2026 vintages are performing within expectations is encouraging but unverified; current delinquency measures exclude consumer finance in some reporting, and stable consumer-finance NPLs may lag deterioration.

The shift toward licensed consumer finance could improve resilience versus less-regulated loan facilitators over time, but it also concentrates the business in balance-sheet lending. Falling funding costs help, yet do not offset higher credit costs if loss severity or recovery timing worsens. The tax charge is noncash in part, but expected dividend-related withholding connects offshore funding needs to domestic cash mobility; verify the convertible-note redemption timetable and subsidiary-level liquidity rather than treating headline cash as fully fungible.

Near term (weeks to 1–3 months), collection-rule recalibration and weak SME/consumer demand remain the swing factors; management itself expects some pressure to persist into year-end. Over 6–18 months, the thesis hinges on whether tighter selection, in-house collections and licensing advantages produce lower vintage losses without sacrificing economics. The contrarian point: sequentially better DPD figures in the non-consumer-finance book can look reassuring while rising C-M3 and elevated impairments signal risk still moving through the pipeline. No valuation or market-pricing data is supplied, so avoid assuming the earnings deterioration is fully reflected.

Key Decisions for Investors

• Keep LU underweight / do not add on the consumer-finance growth narrative alone. Reassess after the next results show C-M3 stabilizing or declining and credit impairment losses easing; a further increase in C-M3 or provisions would falsify the stabilization case.
• Treat LU as a recovery-and-vintage-risk watch, not a clean growth trade. Request vintage-level loss and recovery data, consumer-finance delinquency definitions, and subsidiary-level cash availability before sizing a position.
• For a relative-value screen, compare LU with more asset-light Chinese loan facilitators: favor businesses demonstrably able to pass credit risk through to funding partners, but do not initiate a pair without verified current risk-retention and valuation data.
• Monitor the next 1–3 months for collection-rule clarity, recovery performance, and the convertible-note/offshore funding timetable. Consider defined-risk downside protection only if option liquidity and implied volatility make the premium acceptable; neither is provided here.